4//SEC Filing
MAP Pharmaceuticals, Inc. 4
Accession 0001181431-08-005280
CIK 0001401923operating
Filed
Jan 23, 7:00 PM ET
Accepted
Jan 24, 6:53 PM ET
Size
5.9 KB
Accession
0001181431-08-005280
Insider Transaction Report
Form 4
SHREWSBURY STEPHEN B
Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy
2008-01-22$13.12/sh+40,000$524,800→ 40,000 totalExercise: $13.12Exp: 2018-01-21→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]The option is exercisable as it vests: 25% of the total number of option shares vests and becomes exercisable on January 22, 2009. Thereafter, 1/48th of the total number of option shares becomes exercisable cumulatively on the 22nd day of each following month for 36 months so that the entire number of option shares becomes fully vested and exercisable on January 22, 2012.
Documents
Issuer
MAP Pharmaceuticals, Inc.
CIK 0001401923
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001401923
Filing Metadata
- Form type
- 4
- Filed
- Jan 23, 7:00 PM ET
- Accepted
- Jan 24, 6:53 PM ET
- Size
- 5.9 KB